About US
Contact us
-
GlaxoSmithKline, Merck offer GAVI 95% discount on HPV vaccinesGlaxoSmithKline ($GSK) and Merck ($MRK) are slashing the prices of their HPV vaccinations in a deal with the GAVI Alliance, which delivers immunizations to the developing world. It's the first big pu2013/5/10
-
Unhappy with price caps at home, Indian drugmakers eye more U.S. growthIt's no big secret that international drugmakers are miffed at India. Revoking a few drug patents and overriding others will do that. But India's own pharma companies have their own beef with governm2013/5/9
-
Biogen's HQ plans change, thanks to early Tecfidera successWhat happens when a new drug comes charging out of the launch gate? For Biogen Idec ($BIIB), it means a rethink of its real estate plans. Its fast-growing staff won't all fit in the new headquarters2013/5/9
-
Don't confuse Kadcyla with Herceptin, FDA saysThe FDA is picky about drug names. It's been known to reject brand monikers because they're too similar to others already out there in the market, worried that harried physicians and pharmacists migh2013/5/8
-
Merck shows signs of life in consumer health with new promo campaignMerck & Co. hasn't spent huge amounts of time and resources pushing its consumer health business. While other Big Pharmas like Sanofi ($SNY) and GlaxoSmithKline ($GSK) went around the world snapp2013/5/8
-
ALM201 licensed to South Korean pharmaceutical for developmentThe novel anti-angiogenic peptide ALM2012 has been licensed to a South Korean pharmaceutical company for clinical development and marketing. That is according to a statement issued by the Northern Ir2013/5/7
-
Indian watchdogs pull J&J plant's license on baby-powder sterilization issueJohnson & Johnson is busy negotiating with Asian regulators these days. As FiercePharma reported Friday, South Korean regulators forced the company to halt production at an over-the-counter drug2013/5/7
-
GSK monitored parents' online vaccination discussions for 2 monthsGlaxoSmithKline ($GSK) has been listening to parents' concerns about childhood vaccinations. Really listening. In fact, it has used big data analytics to sift through thousands of comments from Inter2013/5/6
-
J&J issue in South Korea reminiscent of OTC problems hereDrugmakers hope to export their success to emerging markets so they can reap big rewards, but Johnson & Johnson's ($JNJ) Janssen unit appears to have taken a backward approach in South Korea, whe2013/5/6
-
Sanofi taps new EVPs in commercial operations re-orgSanofi ($SNY) is rejigging its commercial operations, with two new executive vice presidents stepping up to the plate to replace the retiring global operations President Hanspeter Spek. Peter Guenter2013/5/3